Che Lin, Jiang Rongjuan, Wang Chengqiang, He Junling, Zhang Zhiyong, Qian Bo
State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.
Guangzhou National Laboratory, Guangzhou, China.
Int J Surg. 2025 Jun 20. doi: 10.1097/JS9.0000000000002680.
Laboratory evidence has recently shown that exposure to organophosphate flame retardants (OPFRs) can cause adverse liver outcomes, which lacks further validation.
The present study investigated the correlation and toxicological mechanism between OPFRs exposure and hepatic steatosis or fibrosis.
To explore the association of OPFRs exposure with hepatic steatosis and liver fibrosis, we conducted the population analysis using the data of urinary OPFRs monitoring and liver vibration-controlled transient elastography (VCTE) examinations from the National Health and Nutrition Examination Survey (NHANES) during 2017-2018. Network toxicology and transcriptomics analysis were used to explore the potential toxicological mechanisms of OPFRs-associated hepatic steatosis.
Single relationship analysis suggested that urinary bis(1,3-dichloro-2-propyl) phosphate (BDCIPP) level was negatively correlated with the risk of hepatic steatosis. Nonlinear relationships were observed between urinary diphenyl phosphate (DPHP) levels and the risk of hepatic steatosis in restricted cubic splines (RCS) analysis. Network toxicology and transcriptomics analysis suggested that OPFRs might directly interact with several metabolism-related proteins, including monoglyceride lipase (MGLL), fatty acid amide hydrolase (FAAH), cannabinoid receptor 1 (CNR1), CNR2, and phosphatidylinositol-5-phosphate 4-kinase type 2 gamma (PIP4K2C). This might affect the lipid metabolic processes by altering the lipid metabolism (e.g., PPAR signaling pathway and insulin signaling pathway), energy metabolism (e.g., adipocytokine signaling pathway and HIF-1 signaling pathway), and apoptosis pathway (e.g., p53 signaling pathway), thereby inducing hepatic steatosis.
Our results indicate that OPFRs exposure was associated with adverse pathological changes in the liver.
A population, network toxicology, and bioinformatics study for the association of organophosphate flame retardant exposure with hepatic steatosis and liver fibrosis.
实验室证据最近表明,接触有机磷酸酯阻燃剂(OPFRs)会导致不良肝脏结局,但这一结论缺乏进一步验证。
本研究调查了OPFRs暴露与肝脂肪变性或肝纤维化之间的相关性及毒理学机制。
为探究OPFRs暴露与肝脂肪变性和肝纤维化的关联,我们利用2017 - 2018年美国国家健康与营养检查调查(NHANES)中尿OPFRs监测数据和肝脏振动控制瞬时弹性成像(VCTE)检查数据进行了人群分析。采用网络毒理学和转录组学分析来探究OPFRs相关肝脂肪变性的潜在毒理学机制。
单因素关系分析表明,尿双(1,3 - 二氯 - 2 - 丙基)磷酸酯(BDCIPP)水平与肝脂肪变性风险呈负相关。在受限立方样条(RCS)分析中,观察到尿二苯基磷酸酯(DPHP)水平与肝脂肪变性风险之间存在非线性关系。网络毒理学和转录组学分析表明,OPFRs可能直接与几种代谢相关蛋白相互作用,包括单酰甘油脂肪酶(MGLL)、脂肪酸酰胺水解酶(FAAH)、大麻素受体1(CNR1)、CNR2和磷脂酰肌醇 - 5 - 磷酸4 - 激酶2γ型(PIP4K2C)。这可能通过改变脂质代谢(如过氧化物酶体增殖物激活受体信号通路和胰岛素信号通路)、能量代谢(如脂肪细胞因子信号通路和缺氧诱导因子 - 1信号通路)和凋亡通路(如p53信号通路)来影响脂质代谢过程,从而诱导肝脂肪变性。
我们的结果表明,OPFRs暴露与肝脏的不良病理变化有关。
一项关于有机磷酸酯阻燃剂暴露与肝脂肪变性和肝纤维化关联的人群、网络毒理学和生物信息学研究。